Targets to trials in diabetic complications.
Diabetes is now the leading cause of end-stage renal disease, blindness, lower-extremity amputations and impotence. In addition, the risk of death from cardiovascular disease such as myocardial infarction and stroke is more than doubled in diabetics. In September 2001, scientists from around the world met in Melbourne to discuss the mechanisms underlying neuronal and vascular changes in diabetic complications. This report summarizes the meeting and attempts to identify potential targets for drug intervention in diabetic complications. (c) 2001 Prous Science. All rights reserved.
Doggrell
Sheila A.
SA
Department of Physiology and Pharmacology, The University of Queensland, Brisbane, Queensland, Australia. s_doggrell@yahoo.com